Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05514470

Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress

Impact of Loss-of-function Mutations of Genes Encoding Cytosolic Aminoacyl-tRNA Synthetases on Protein Translation and Responses to Cellular Stress

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Mutations in the genes encoding cytosolic aminoacyl-tRNA synthetases are responsible for early-onset multisystemic diseases including to varying degrees interstitial lung disease, liver damage, neurological and digestive disorders, and systemic inflammation. These are rare and severe diseases whose pathophysiology is poorly understood. The investigative team hypothesizes that mutations within these genes are responsible for a decrease in protein translation and lead to a cellular stress response similar to that induced by amino acid deprivation. The investigative team also hypothesizes that these alterations could be corrected by high-dose supplementation in the culture medium of the corresponding amino acid. The main objective of the study is to precisely determine the consequences of cytosolic aminoacyl-tRNA synthetase mutations at the cell level on protein translation.

Detailed description

Mutations in the genes encoding cytosolic aminoacyl-tRNA synthetases are responsible for early-onset multisystemic diseases including to varying degrees interstitial lung disease, liver damage, neurological and digestive disorders, and systemic inflammation. These are rare and severe diseases whose pathophysiology is poorly understood. The investigative team hypothesizes that mutations within these genes are responsible for a decrease in protein translation and lead to a cellular stress response similar to that induced by amino acid deprivation. The investigative team also hypothesizes that these alterations could be corrected by high-dose supplementation in the culture medium of the corresponding amino acid. The main objective of the study is to precisely determine the consequences of cytosolic aminoacyl-tRNA synthetase mutations at the cell level on protein translation. The parameters below will be studied in vitro in cell culture from skin biopsies of patients and control cells: * Determination of total protein content * The incorporation of d-methionine, leucine, tyrosine or phenylalanine into proteins * The study of polysomes profiling * The study of the assembly of the ribosomal 43S pre-initiation complex * The phosphorylation of eIF2α and 4EBP and the expression of ATF4 * Ribosome profiling * Transfer RNA (tRNA) sequencing * The production of reactive oxygen species (ROS) The results of these studies will be compared: * Between patient cells and control cells * Between genetically corrected patient cells, by stable transfection of the wild-type cDNA of the concerned genes and uncorrected cells * Between patient cells cultured in medium enriched with the corresponding amino acid.

Conditions

Interventions

TypeNameDescription
OTHERSkin biopsyA skin biopsy performed on the forearm or thigh depending on the patient's age and wishes, with a biopsy punch with a diameter of 3 to 4 mm depending on the child's age (3 for children under 3 years, 4 beyond). Culture of fibroblasts and immortalization.

Timeline

Start date
2024-11-01
Primary completion
2027-11-01
Completion
2027-11-01
First posted
2022-08-24
Last updated
2025-09-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05514470. Inclusion in this directory is not an endorsement.